Corundum Systems Biology

Japanese investment firm specializing in systems biology and life sciences. Focus on computational approaches to drug discovery and therapeutics development, bridging Japanese innovation with global markets.

Location
Tokyo, Japan
Founded
2010
AUM
¥50B+
Investment Range
¥100M - ¥1B
Portfolio Companies
9
Focus
biotech-focused
Fund Stages
seed, series-a, series-b

Portfolio Companies

NameLocationFoundedCategories
VerteroBoston, Massachusetts, USA-
biotechsystems-biology+1
HolobiomeCambridge, Massachusetts, USA2015
biotechmicrobiome+2
Freya BiosciencesSouth San Francisco, California, USA2019
therapeuticsbiotech+2
Concerto BiosciencesCambridge, Massachusetts, USA2020
microbiometherapeutics+3
SequentialSan Francisco, California, USA2019
microbiomediagnostics+2
KulaOmicsSingapore2019
genomicsmulti-omics+3
Pheno.AITel Aviv, Israel2019
ai-drug-discoveryhealthcare-platform+2
ImYooBoston, Massachusetts, USA2019
biotechhealthcare+1
Nimble Science--
biotechsystems-biology+1